Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for August 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Treatment Guidelines Updated for Ankylosing Spondylitis, Axial SpA
WEDNESDAY, Aug. 28, 2019 (HealthDay News) -- In a special article published online Aug. 21 in Arthritis Care & Research, the American College of Rheumatology, Spondylitis Association of America, and Spondyloarthritis Research and Treatment Network present updated recommendations for the treatment of ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA).
CT Scan Screen for Lung Cancer Can ID Smoking-Related Diseases
TUESDAY, Aug. 27, 2019 (HealthDay News) -- Lung cancer screening (LCS) computed tomography (CT) scans can be used to identify smoking-related conditions that frequently are associated with adverse events, according to a study published in the July issue of Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation.
Combo Tx May Improve Disease Control for Some in Early RA
TUESDAY, Aug. 27, 2019 (HealthDay News) -- For patients with early rheumatoid arthritis (RA) and high disease activity, the combination of a tumor necrosis factor (TNF) or non-TNF biologic with methotrexate improves disease control, remission, and functional capacity compared with monotherapy, according to a review published online Aug. 6 in the Journal of General Internal Medicine.
Antibiotic Use Tied to Higher Risk for Rheumatoid Arthritis
FRIDAY, Aug. 23, 2019 (HealthDay News) -- Antibiotic prescriptions are associated with a higher risk for rheumatoid arthritis (RA), according to a study published online Aug. 7 in BMC Medicine.
Recommendations Developed for Management of Lyme Disease
FRIDAY, Aug. 16, 2019 (HealthDay News) -- The Infectious Diseases Society of America, the American Academy of Neurology, and the American College of Rheumatology have released a draft of their joint clinical practice guidelines for the management of Lyme disease.
Advertising Can Promote Interest in Health-Related Research
THURSDAY, Aug. 15, 2019 (HealthDay News) -- Advertising current local health-related research using large TV monitors in emergency department waiting rooms can increase the short-term interest in health-related research, according to a study published online Aug. 1 in BMJ Open.
Non-Hospital-Based Provider-to-Patient Telehealth Use Growing
TUESDAY, Aug. 13, 2019 (HealthDay News) -- Use of non-hospital-based provider-to-patient telehealth grew almost 1,400-fold from 2014 to 2018, according to a FAIR Health White Paper.
One-Third of Physicians Will Take 10+ Years to Pay Off Debt
MONDAY, Aug. 12, 2019 (HealthDay News) -- Nearly two-thirds of actively practicing physicians are still carrying medical school debt, according to the Medical School Debt Report 2019, published by the staffing firm Weatherby Healthcare.
Giant Cell Arteritis Occurs at Similar Rate in Blacks, Whites
FRIDAY, Aug. 9, 2019 (HealthDay News) -- Biopsy-proven giant cell arteritis (BP-GCA) occurs at a similar rate among white and black patients, according to a study published online Aug. 8 in JAMA Ophthalmology.
Ulcerative Colitis Outcomes Similar for Smokers, Nonsmokers
FRIDAY, Aug. 9, 2019 (HealthDay News) -- Smokers and nonsmokers with ulcerative colitis (UC) have similar outcomes, according to a study published online Aug. 6 in Alimentary Pharmacology and Therapeutics.
NSAIDs Contribute to Increased CVD Risk in Osteoarthritis
THURSDAY, Aug. 8, 2019 (HealthDay News) -- Osteoarthritis (OA) is an independent risk factor for increased cardiovascular disease (CVD), and nonsteroidal anti-inflammatory drugs (NSAIDs) contribute substantially to this risk, according to a study published online Aug. 6 in Arthritis & Rheumatology.
Medicare Spending on Essential Medicines Up 116 Percent From 2011 to 2015
WEDNESDAY, Aug. 7, 2019 (HealthDay News) -- Spending associated with essential medicines grew substantially from 2011 to 2015 for Medicare Part D beneficiaries, according to a study published online July 17 in The BMJ.
Brand-Brand Competition Has Not Cut Prices in Pharma Market
FRIDAY, Aug. 2, 2019 (HealthDay News) -- Brand-brand competition in the U.S. pharmaceutical market has not lowered drug list prices, according to a review published online July 30 in PLOS Medicine.
Trump Admin Announces Plan to Allow Drug Imports From Canada
THURSDAY, Aug. 1, 2019 (HealthDay News) -- Americans could import less expensive prescription drugs from Canada under a plan being developed by the Trump administration.